iAnthus Capital Holdings (FRA:2IA) Net Margin %: -42.70% (As of Mar. 2026)


What is iAnthus Capital Holdings Net Margin %?

iAnthus Capital Holdings FRA:2IA Net Margin % is -42.70% as of Mar. 2026. The stock has 4 warning signs investors should review. Among 956 Drug Manufacturers companies, iAnthus Capital Holdings ranks worse than 85.67% on this metric.

Net margin is calculated as Net Income divided by its Revenue. iAnthus Capital Holdings's Net Income for the three months ended in Mar. 2026 was €-12.4 Mil. iAnthus Capital Holdings's Revenue for the three months ended in Mar. 2026 was €29.0 Mil. Therefore, iAnthus Capital Holdings's net margin for the quarter that ended in Mar. 2026 was -42.70%.

The historical rank and industry rank for iAnthus Capital Holdings's Net Margin % or its related term are showing as below:

FRA:2IA' s Net Margin % Range Over the Past 10 Years
Min: -1821.66   Med: -206.61   Max: -4.56
Current: -42.78

FRA:2IA's Net Margin % is ranked worse than
85.67% of 956 companies
in the Drug Manufacturers industry
Industry Median: 5.56 vs FRA:2IA: -42.78

iAnthus Capital Holdings  (FRA:2IA) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

iAnthus Capital Holdings Net Margin % Related Terms

iAnthus Capital Holdings Net Margin % Historical Data

* Premium members only.

The historical data trend for iAnthus Capital Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iAnthus Capital Holdings Net Margin % Chart

iAnthus Capital Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -38.17 -275.34 -48.12 -4.56 -27.92

iAnthus Capital Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.51 -53.20 -35.45 -39.93 -42.70

FRA:2IA vs ZTS: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, iAnthus Capital Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iAnthus Capital Holdings Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, iAnthus Capital Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where iAnthus Capital Holdings's Net Margin % falls into.


iAnthus Capital Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

iAnthus Capital Holdings's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-34.333/122.964
=-27.92 %

iAnthus Capital Holdings's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-12.377/28.986
=-42.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -42.70% mean?
iAnthus Capital Holdings (FRA:2IA) has a Net Margin % of -42.70% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on iAnthus Capital Holdings and its competitors. According to the industry distribution chart, iAnthus Capital Holdings ranks #819 out of 956 companies in the Drug Manufacturers industry, placing it in the top 85.7%.
Is iAnthus Capital Holdings' Net Margin % too high?
iAnthus Capital Holdings' current Net Margin % is -42.70%. Based on the distribution chart, iAnthus Capital Holdings ranks #819 out of 956 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does iAnthus Capital Holdings' Net Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, iAnthus Capital Holdings ranks #819 out of 956 companies for Net Margin %. This places iAnthus Capital Holdings in the lower half of its industry. The industry median Net Margin % is 5.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on iAnthus Capital Holdings and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iAnthus Capital Holdings's current Net Margin % is -42.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iAnthus Capital Holdings stock overvalued right now?
iAnthus Capital Holdings (FRA:2IA) has a current Net Margin % of -42.70%. The current Net Margin % is -42.70%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For iAnthus Capital Holdings (FRA:2IA), the current Net Margin % is -42.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

iAnthus Capital Holdings Business Description

Other Exchanges ITHUF:USAIAN:Canada
Address 214 King Street West, Suite 314, Toronto, ON, CAN, M5H 3S6
iAnthus Capital Holdings Inc is a vertically-integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities and a developer, producer, and distributor of branded cannabis products in the United States. Its Cannabis product offerings include flower and trim, products containing cannabis flower and trim (such as packaged flower and pre-rolls), cannabis infused products (such as topical creams and edibles), and products containing cannabis extracts (such as vape cartridges, concentrates, live resins, wax products, oils, and tinctures). The company's reportable operating segments are the Eastern Region, which generates the maximum revenue, and the Western Region.